News and commentary from the endocrinology world
How GLP-1 drugs are reshaping medicine
But how to achieve equitable use remains "complicated," says expert
In the third year, 88% of patients could go 12 weeks or longer with 8-mg dose
Ophthalmologists hope expanded use will lead to more evaluations in primary clinics